BusinessCORRECTING and REPLACING -- Cempra to Present at Upcoming Investor ConferencesBy Nasdaq OMXFeb 8, 2017, 2:41 PM UTC
BusinessToyama Chemical (a Subsidiary of FUJIFILM Holdings Corporation) Begins Phase 3 Studies in Japan With Cempra’s SolithromycinBy Nasdaq OMXDec 5, 2016, 1:01 PM UTC
BusinessCempra Announces Anti-NASH Effects of Solithromycin: Interim Results From Phase 2 StudyBy Nasdaq OMXSep 29, 2016, 8:15 PM UTC
BusinessCempra to Present at the Cowen and Company 36th Annual Healthcare ConferenceBy Nasdaq OMXFeb 29, 2016, 12:30 PM UTC
